Last reviewed · How we verify

NCT07135076: PARADIES

PARodontitis And Type 2 DIabetes in Elderly Subjects

Completed Last updated 21 August 2025
What this trial tests

trial in Parodontitis in 1,296 participants. Completed in 31 December 2019.

Timeline
1 July 2017
Primary endpoint
1 July 2019
31 December 2019

Quick facts

Lead sponsorGerman Institute of Human Nutrition
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,296
Start date1 July 2017
Primary completion1 July 2019
Estimated completion31 December 2019
Sites2 locations across Germany

Conditions studied

Sponsor

German Institute of Human Nutrition

Who can join

18 and older, any sex, with Parodontitis or Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PARADIES is a cross-sectional observational study on Parodontitis and Type-2-diabetes. Its purpose is to collect data on the prevalence of Parodontitis and Type-2-diabetes in a regular out-patient setting, to provide insight into predictive conditions (such as comorbidities, blood parameters, clinical symptoms etc.)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Parodontitis

Currently open trials in the same condition.

Other German Institute of Human Nutrition trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07135076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing